Tmax in three treatment, three period, three sequence design [Nonparametrics]

posted by libaiyi – China, 2019-04-09 09:15 (2011 d 12:39 ago) – Posting: # 20134
Views: 3,575

Dear all,

I have a question about Wilcoxon signed rank test on Tmax. In a three treatment, three period, three sequece design (two test formulations and one reference formulation with the sequences as T1-R-T2, R-T2-T1, and T2-T1-R), can we use Wilcoxon signed rank test for Tmax? If not, what can we do to statistically evaluate Tmax?

Thanks in advance!

Best,

Libaiyi

Complete thread:

UA Flag
Activity
 Admin contact
23,249 posts in 4,885 threads, 1,652 registered users;
63 visitors (0 registered, 63 guests [including 6 identified bots]).
Forum time: 21:54 CEST (Europe/Vienna)

The rise of biometry in this 20th century,
like that of geometry in the 3rd century before Christ,
seems to mark out one of the great ages or critical periods
in the advance of the human understanding.    R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5